March 21, 2013
Differential diagnosis of dementia in patients with equivocal clinical presentations may be sharpened with an imaging technique recently approved for other purposes, a researcher said here.
SPECT imaging with a radioactive iodine-based tracer -- sold under the name DaTscan -- distinguished patients with Lewy body dementia and non-amnestic mild cognitive impairment (MCI) from those with Alzheimer's disease and amnestic MCI in a pilot study, said Bradley Boeve, MD, of the Mayo Clinic in Rochester, Minn.